Piramal Pharma invests over Rs 69 crore to expand its API capability Medical Dialogues Bureau21 Jun 2019 10:00 AM ISTThe new wing at the Riverview site is dedicated to the production of HPAPIs with low occupational exposure levels (OELs), Piramal Pharma Solutions...
Bayer Stivarga becomes first drug to be tested in brain cancer patients in multi-arm cooperation trial Farhat Nasim21 Jun 2019 9:15 AM ISTBayer's Stivarga will be the first drug to be evaluated in this trial.New Delhi: Bayer announced today that the Stivarga (regorafenib) arm of the...
Merck CEO sees legal challenge if US adopts drug pricing based on other countries Medical Dialogues Bureau21 Jun 2019 9:00 AM ISTEarlier on Thursday, Merck executives touted the company's pipeline of experimental drugs beyond its blockbuster cancer treatment Keytruda.NEW YORK:...
Caplin Point's sterile injectable site in Chennai gets two USFDA observations Medical Dialogues Bureau20 Jun 2019 1:34 PM ISTNew Delhi: Caplin Point Laboratories Monday said the US health regulator has made two observations after completion of inspection at its subsidiary's...
Glenmark Pharma gets tentative nod from USFDA for acne treatment drug Medical Dialogues Bureau20 Jun 2019 1:33 PM ISTNew Delhi: Glenmark Pharmaceuticals Thursday it has received tentative approval from the US health regulator for Clindamycin Phosphate Foam, used to...
Indian Pharma aspiring to grow to 120-130 billion Dollar Industry by 2030: IPA Medical Dialogues Bureau20 Jun 2019 1:29 PM ISTNEW DELHI: The Indian pharmaceutical industry is aspiring to touch USD 120-130 billion by 2030 from the current USD 38 billion, industry body Indian...
AstraZeneca's Lynparza gets EU nod as first-line ovarian cancer maintenance treatment Medical Dialogues Bureau19 Jun 2019 12:02 PM ISTBritish drugmaker AstraZeneca Plc on Tuesday said its cancer medicine Lynparza was approved as a first-line maintenance treatment for a type of...
Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH Medical Dialogues Bureau19 Jun 2019 12:01 PM ISTAHMEDABAD: Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has completed enrolment of 104 patients with...
Roche wins Japan approval for personalised cancer drug Rozlytrek Medical Dialogues Bureau19 Jun 2019 12:01 PM ISTZURICH: Swiss drugmaker Roche on Tuesday won approval in Japan for Rozlytrek as the world's biggest maker of cancer drugs pushes ahead in personalised...
Sanofi to Partner with Google to use AI, Deep Analytics to find better treatments Medical Dialogues Bureau19 Jun 2019 11:58 AM ISTPARIS: French pharmaceutical firm Sanofi said Tuesday it is partnering with Google to use artificial intelligence and deep analytics tools to sift...
GSK pharma head flags need for speed in high-pressure drug market Medical Dialogues Bureau18 Jun 2019 2:06 PM ISTLONDON: Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at...
Cadila Healthcare gets EIR report on Ahmedabad SEZ facility Medical Dialogues Bureau18 Jun 2019 1:57 PM ISTNew Delhi: Drug firm Cadila Healthcare Monday said it has received establishment inspection report from the US health regulator with voluntary action...
